New study tracks Real-World prostate cancer treatments across canada
NCT ID NCT06874114
First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times
Summary
This study collects information from medical records of 700 Canadian men with metastatic hormone-sensitive prostate cancer (mHSPC). Researchers want to see how doctors actually combine treatments like hormone therapy, newer drugs, or chemotherapy in everyday practice. No new treatments or changes to care are given—only existing data is reviewed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pentavere
Toronto, Ontario, M6G 1A1, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Half the dose, same hope? trial tests cutting hormone therapy in prostate cancer
- Which prostate cancer drug is safer for the heart? new study aims to find out
- Exercise study aims to boost quality of life for men with metastatic prostate cancer
- New cocktail aims to stall spread of prostate cancer
- Prostate cancer Pill-Taking habits under the microscope
- New model predicts prostate cancer treatment response using PET scans